These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29134256)

  • 1. [Extragenital, disseminated infection with human papillomaviruses : Therapeutic response through vaccination with HPV].
    Wiskemann L; Durani B; Hartschuh W
    Hautarzt; 2018 Mar; 69(3):245-248. PubMed ID: 29134256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men Second Report: Negative Conversion of HPV in Laryngeal Secretions.
    Hirai R; Makiyama K; Matsuzaki H; Oshima T
    J Voice; 2018 Jul; 32(4):488-491. PubMed ID: 28866231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intersurgical interval increased with use of quadrivalent human papillomavirus vaccine (Gardasil) in a pediatric patient with recurrent respiratory papillomatosis: A case report.
    Baumanis MM; Elmaraghy CA
    Int J Pediatr Otorhinolaryngol; 2016 Dec; 91():166-169. PubMed ID: 27863633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis.
    Tjon Pian Gi RE; San Giorgi MR; Pawlita M; Michel A; van Hemel BM; Schuuring EM; van den Heuvel ER; van der Laan BF; Dikkers FG
    Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3231-6. PubMed ID: 27188508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of Routine HPV Vaccination in the Management of Recurrent Respiratory Papillomatosis.
    Yiu Y; Fayson S; Smith H; Matrka L
    Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):309-315. PubMed ID: 30595025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gardasil Vaccination for Recurrent Laryngeal Papillomatosis in Adult Men: First Report: Changes in HPV Antibody Titer.
    Makiyama K; Hirai R; Matsuzaki H
    J Voice; 2017 Jan; 31(1):104-106. PubMed ID: 27068425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL; Joura EA
    BioDrugs; 2011 Oct; 25(5):339-43. PubMed ID: 21942919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of the quadrivalent human papillomavirus vaccine (gardasil) as adjuvant therapy in the treatment of recurrent respiratory papilloma.
    Young DL; Moore MM; Halstead LA
    J Voice; 2015 Mar; 29(2):223-9. PubMed ID: 25619468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the human papillomavirus (types 6, 11, 16, and 18) vaccine in the treatment of children with recurrent respiratory papillomatosis.
    Hermann JS; Weckx LY; Monteiro Nürmberger J; Santos Junior GF; Campos Pignatari AC; Nagata Pignatari SS
    Int J Pediatr Otorhinolaryngol; 2016 Apr; 83():94-8. PubMed ID: 26968061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study.
    Coskuner ER; Ozkan TA; Karakose A; Dillioglugil O; Cevik I
    J Sex Med; 2014 Nov; 11(11):2785-91. PubMed ID: 25124237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination.
    Östensson E; Fröberg M; Leval A; Hellström AC; Bäcklund M; Zethraeus N; Andersson S
    PLoS One; 2015; 10(9):e0139062. PubMed ID: 26398189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment With Quadrivalent Human Papillomavirus Vaccine for Juvenile-Onset Recurrent Respiratory Papillomatosis: Case Report and Review of the Literature.
    Katsuta T; Miyaji Y; Offit PA; Feemster KA
    J Pediatric Infect Dis Soc; 2017 Nov; 6(4):380-385. PubMed ID: 28992265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focal epithelial hyperplasia by human papillomavirus (HPV)-32 misdiagnosed as HPV-16 and treated with combination of retinoids, imiquimod and quadrivalent HPV vaccine.
    Gemigniani F; Hernández-Losa J; Ferrer B; García-Patos V
    J Dermatol; 2015 Dec; 42(12):1172-5. PubMed ID: 26047065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papilloma virus vaccination in Nepal: an initial experience in Nepal.
    Singh Y; Shah A; Singh M; Verma S; Shrestha BM; Vaidya P; Nakarmi RP; Shrestha SB
    Asian Pac J Cancer Prev; 2010; 11(3):615-7. PubMed ID: 21039025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis.
    Malagón T; Drolet M; Boily MC; Franco EL; Jit M; Brisson J; Brisson M
    Lancet Infect Dis; 2012 Oct; 12(10):781-9. PubMed ID: 22920953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of Gardasil among mid-adult aged men (27-45 years)--The MAM Study.
    Giuliano AR; Isaacs-Soriano K; Torres BN; Abrahamsen M; Ingles DJ; Sirak BA; Quiterio M; Lazcano-Ponce E
    Vaccine; 2015 Oct; 33(42):5640-5646. PubMed ID: 26343499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human papillomaviruses].
    Gross G
    Ther Umsch; 2003 Oct; 60(10):595-604. PubMed ID: 14610898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel candidate HPV vaccine: MS2 phage VLP displaying a tandem HPV L2 peptide offers similar protection in mice to Gardasil-9.
    Zhai L; Peabody J; Pang YS; Schiller J; Chackerian B; Tumban E
    Antiviral Res; 2017 Nov; 147():116-123. PubMed ID: 28939477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil).
    Siddiqui MA; Perry CM
    Drugs; 2006; 66(9):1263-71; discussion 1272-3. PubMed ID: 16827602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.